Sender Company & Partners’s Pfizer PFE Stock Holding History

Sender Company & Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,056	Closed	-$293K	–	96
2024 Q4	$293K	Buy	11,056 +2,535	+30%	+$68.8K	0.27%	52
2024 Q3	$247K	Sell	8,521 -9,305	-52%	-$271K	0.3%	40
2024 Q2	$499K	Buy	+17,826	New	+$491K	0.57%	24
2022 Q2	–	Sell	-46,224	Closed	-$2.39M	–	50
2022 Q1	$2.39M	Buy	+46,224	New	+$2.4M	2.56%	10

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sender Company & Partners's PFE Position: Q1 2025 in Review

Sender Company & Partners sold out of Pfizer (PFE) in Q1 2025, closing a stake of 11,056 shares — an estimated $293K sold.

Sender Company & Partners first reported a position in PFE in Q1 2022 and held it in 4 quarters. The position peaked at $2.39M in Q1 2022. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Sender Company & Partners reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Sender Company & Partners sold 11,056 Pfizer shares in Q1 2025, an estimated $293K.
Sender Company & Partners first reported a position in Pfizer in Q1 2022 and held it in 4 quarters.
Sender Company & Partners's Pfizer position peaked at $2.39M in Q1 2022.
2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Sender Company & Partners's 13F filing for Q1 2025, filed 16 May 2025.